HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela A Bota Selected Research

rindopepimut

1/2020Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
1/2014The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela A Bota Research Topics

Disease

27Neoplasms (Cancer)
01/2022 - 10/2007
17Glioblastoma (Glioblastoma Multiforme)
01/2022 - 09/2012
16Glioma (Gliomas)
07/2019 - 10/2007
7Brain Neoplasms (Brain Tumor)
01/2020 - 10/2007
6Cognitive Dysfunction
01/2022 - 05/2014
3Leukemia
03/2020 - 10/2009
2Lymphoma (Lymphomas)
03/2020 - 10/2009
2Sarcoma (Soft Tissue Sarcoma)
03/2020 - 01/2017
2Meningioma (Meningiomas)
01/2020 - 10/2011
1COVID-19
01/2022
1Carcinogenesis
10/2021
1Medulloblastoma
10/2021
1Fatigue
01/2021
1Inflammation (Inflammations)
01/2021
1Headache (Headaches)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Confusion (Bewilderment)
01/2021
1Necrosis
03/2020
1Breast Neoplasms (Breast Cancer)
03/2020
1Cardiomyopathies (Cardiomyopathy)
03/2020
1Heart Failure
03/2020
1Chemotherapy-Related Cognitive Impairment
01/2017
1Mitochondrial Diseases (Mitochondrial Disease)
01/2017
1Disease Progression
01/2017
1Atrophy
01/2016
1Multiple Myeloma
01/2016
1Ovarian Neoplasms (Ovarian Cancer)
12/2014
1Hypoxia (Hypoxemia)
12/2013
1Optic Nerve Diseases (Optic Neuropathy)
07/2013
1Seizures (Absence Seizure)
06/2013

Drug/Important Bio-Agent (IBA)

13Bevacizumab (Avastin)FDA Link
01/2022 - 01/2013
9Temozolomide (Temodar)FDA LinkGeneric
01/2022 - 12/2013
7VaccinesIBA
01/2020 - 01/2015
4Proteasome InhibitorsIBA
10/2021 - 12/2013
4Cisplatin (Platino)FDA LinkGeneric
01/2017 - 05/2014
3Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2012
3Proteasome Endopeptidase Complex (Proteasome)IBA
10/2021 - 12/2013
2marizomibIBA
01/2021 - 01/2016
2Biological ProductsIBA
01/2021 - 12/2014
2epidermal growth factor receptor VIIIIBA
01/2020 - 01/2014
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020 - 10/2011
2rindopepimutIBA
01/2020 - 01/2014
2Pharmaceutical PreparationsIBA
01/2020 - 12/2013
2Octreotide (Sandostatin)FDA LinkGeneric
01/2020 - 10/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2017
2AntigensIBA
08/2018 - 05/2015
2Methotrexate (Mexate)FDA LinkGeneric
01/2017 - 10/2009
2Bortezomib (Velcade)FDA Link
01/2016 - 12/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2014 - 12/2013
2Messenger RNA (mRNA)IBA
12/2014 - 09/2012
1NivolumabIBA
01/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1EpitopesIBA
01/2022
1pembrolizumabIBA
01/2022
1Apoptosis Regulatory ProteinsIBA
10/2021
1UbiquitinIBA
10/2021
1CaspasesIBA
10/2021
1pro-brain natriuretic peptide (1-76)IBA
03/2020
1Biomarkers (Surrogate Marker)IBA
03/2020
1Brain Natriuretic Peptide (Natrecor)FDA Link
03/2020
1Troponin T (Troponin T1)IBA
03/2020
1AnthracyclinesIBA
03/2020
1Epidermal Growth Factor (EGF)IBA
01/2020
1Alkylating AgentsIBA
01/2020
1keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA
01/2020
1ProgesteroneFDA LinkGeneric
01/2020
1thiamine triphosphorate (TTP)IBA
01/2020
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2020
1Estrogens (Estrogen)FDA Link
01/2020
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
07/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Neoplasm Antigens (Tumor Antigens)IBA
08/2018
1(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
04/2018
1CytokinesIBA
01/2018
1PlatinumIBA
01/2017
1Reticulin (Reticular Fiber)IBA
01/2017
1Acetylcysteine (Siran)FDA LinkGeneric
01/2017
1Free RadicalsIBA
01/2017
1Small Interfering RNA (siRNA)IBA
11/2016
1Oxygen (Dioxygen)IBA
11/2016
1Mitochondrial DNA (mtDNA)IBA
11/2016
1carfilzomibIBA
01/2016
1AutoantigensIBA
05/2015
1ErbB Receptors (EGF Receptor)IBA
12/2014
1tanespimycin (17AAG)IBA
12/2014
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2014
1Mitogen-Activated Protein KinasesIBA
12/2014
1Caspase 3 (Caspase-3)IBA
12/2013
1LacosamideFDA Link
06/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
06/2013
1Endothelial Growth FactorsIBA
01/2013
1HLA-A Antigens (HLA-A)IBA
09/2012

Therapy/Procedure

15Drug Therapy (Chemotherapy)
01/2022 - 10/2007
10Therapeutics
01/2018 - 10/2007
7Radiotherapy
01/2020 - 10/2011
4Immunotherapy
08/2018 - 01/2010
1Cognitive Training
01/2022
1Chemoradiotherapy
01/2017
1Subcutaneous Injections
12/2013